Actively Recruiting

Phase Not Applicable
Age: 18Years - 64Years
All Genders
ID05985486

The Impact of Weight Loss on Alzheimer's Disease Risk in Adults With Down Syndrome

Led by University of Kansas Medical Center · Updated on 2026-03-11

81

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating whether weight loss or changes in diet can help prevent or delay the development of Alzheimer's disease in adults with Down syndrome who do not have dementia. This study compares the effects of a reduced calorie diet and monthly behavioral counseling with general health education sessions delivered remotely. The goal is to better understand how lifestyle changes may influence Alzheimer's risk in this specific population. Participants will be randomly assigned to either a weight loss group or a general health education control group. The weight loss group will follow a reduced calorie diet focusing on frozen meals and increased fruits and vegetables linked to brain health, attend monthly remote education sessions, and self-monitor their diet and weight using web-based applications. The control group will participate in monthly remote sessions about general health topics. The study lasts 12 months. All participants will visit the University of Kansas Medical Center three times during the year for blood draws, cognitive tests, MRI brain scans, and assessments of height, weight, and dietary intake. Researchers will measure blood markers related to Alzheimer's disease, body weight, diet quality, brain volume, and cognitive function at baseline, 6 months, and 12 months. This allows comprehensive monitoring of health and brain outcomes throughout the study.

CONDITIONS

Brief Title

Brain Outcomes With Lifestyle Change in Down Syndrome

Who Can Participate

Age: 18Years - 64Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of Down syndrome
  • Body Mass Index (BMI) between 25 and 50 kg/m2
  • Ability to communicate through spoken language
  • Ability to attend 3 visits at the University of Kansas Medical Center over 12 months for testing
  • Living at home with a parent or guardian, or in supported living with a caregiver who assists with food shopping, meal planning, and preparation and agrees to help with study visits
Not Eligible

You will not qualify if you...

  • Diagnosis of dementia
  • Insulin dependent diabetes
  • Participation in a diet or physical activity weight management program in the past 6 months
  • Dairy allergy
  • Serious medical risks such as cancer, recent heart attack, stroke, pregnancy, or angioplasty
  • Unwillingness to be randomized
  • Contraindications for MRI, including metal implants, pacemakers, claustrophobia, or inability to lie flat
  • Use of GLP-1 medications
  • Use of anti-amyloid medications

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Outpatient Treatment

Duration - 12 months

Participants follow a reduced calorie diet daily for 12 months with monthly behavioral counseling and education sessions, or attend monthly health education sessions about general health.

Monthly visits for education and counseling

Trial Site Locations

Total: 1 location

1

University of Kansas Medical Center

Kansas City, Kansas, United States, 66160

Actively Recruiting

Loading map...

Research Team

L

Lauren Ptomey, PhD

J

Jessica Danon

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Similar Trials

Comparison of Cardiac [18F]-MFBG PET Versus [123I]-MIBG SPEC...

Parkinson Disease

Actively Recruiting

2 locations

An Open-label, Non-randomized, Multi-center Pivotal Phase 3 ...

Alzheimer Disease

Actively Recruiting

25 locations

A Bilingual Virtually-based Intervention (PEDALL) for the Pr...

Acute Lymphoblastic Leukemia

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Brain outcomes with lifestyle change in adults with Down syndrome: Rationale and design for a 12-month randomized trial.

Lauren T Ptomey, Joseph E Donnelly, Jeffery Burns...

https://pubmed.ncbi.nlm.nih.gov/40329624